Non-alcoholic fatty liver disease (NAFLD) is the most prevalent form of chronic liver disease
in the world, paralleling the epidemic of obesity and Type 2 diabetes mellitus (T2DM) …

The epidemic of obesity has resulted in a parallel incremental burden of nonalcoholic fatty
liver disease (NAFLD) worldwide. Nonalcoholic fatty liver disease includes a spectrum of …

Context and Objective: Nonalcoholic fatty liver disease (NAFLD) and its more severe form
with steatohepatitis (NASH) are common in patients with type 2 diabetes mellitus (T2DM) …

Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease | New England
Journal of Medicine Skip to main content The New England Journal of Medicine homepage …

Background As a result of the increased consumption of sugar-rich and fatty-products, and
the increase in preference for such products, metabolic disorders are becoming more …

Increasing evidence connects non-alcoholic fatty liver disease (NAFLD) to cardiovascular
disease (CVD). The aim of this study is to assess whether and to what extent the excess risk …

Non-alcoholic fatty liver disease (NAFLD) is the hepatic manifestation of the metabolic
syndrome and the incidence of which is rising rapidly due to the increasing epidemic of …

Nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) are
increasingly relevant public health issues owing to their close association with the …

Low-carbohydrate high-fat (LCHF) diets are a highly contentious current topic in nutrition.
This narrative review aims to provide clinicians with a broad overview of the effects of LCHF …

Since the initial description of nonalcoholic steatohepatitis (NASH), several sets of
pathologic criteria for its diagnosis have been proposed. However, their interprotocol …